Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression

Journal of Cellular Physiology

Volumn 210, Issue 1, 2007, Pages 63-71

  Qi, Yitao ^a   Tu, Yiding ^a   Yang, Di ^a   Chen, Qian ^a   Xiao, Jun ^a   Chen, Yiqiang ^a   Fu, Juanling ^b   Xiao, Xilong ^a   Zhou, Zongcan ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; MYC PROTEIN; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM; RNA INTERFERENCE; UPREGULATION;

CELL CYCLE; CELL ENLARGEMENT; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LUNG; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 33845461445     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20816     Document Type: Article

References (46)

1. Alexandrow MG, Moses HL. 1998. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. J Cell Biochem 70(4):528-542.
2. Amati B, Alevizopoulos K, Vlach J. 1998. Myc and the cell-cycle. Front Biosci 3:d250-d268.
3. Beier R, Burgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, Moroy T, Ansorge W, Roberts J, Eilers M. 2000. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J 19(21):5813-5823.
4. Berns K, Hijmans EM, Bernards R. 1997. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15(11):1347-1356.
5. Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R. 2000, p27kip1-independent cell-cycle regulation by MYC. Oncogene 19(42):4822-4827.
6. Born TL, Frost JA, Schonthal A, Prendergast GC, Feramisco JR. 1994. c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol 14(9):5710-5718.
7. Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell-cycle. Oncogene 9(12):3635-3645.
8. Dang CV. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19(1):1-11.
9. Elend M, Eilers M. 1999. Cell growth: Downstream of Myc - to grow or to cycle? Curr Biol 9(24):R936-938.
10. Gartel AL, Shchors K. 2003. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283(1):17-21.
11. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL. 2001. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98(8):4510-4515.
12. Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P. 1999. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97(6):767-777.
13. Henriksson M, Luscher B. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
14. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. 2000. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 97(5):2229-2234.
15. Iritani BM, Eisenman RN. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci USA 96(23):13180-13185.
16. Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P. 1999. Drosophila myc regulates cellular growth during development. Cell 98(6):779-790.
17. Kim YH, Buchholz MA, Chrest FJ, Nordin AA. 1994. Upregulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J Immunol 152(9):4328-4335.
18. Ko JL, Chiao MC, Chang SL, Lin P, Lin JC, Sheu GT, Lee H. 2002. A novel p53 mutant retained functional activity in lung carcinomas. DNA Repair (Amst) 1(9):755-762.
19. Kou-Juey Wu CG, Mario Amacker, Nathalie Simon-Vermot, Axel Polack, Joachim Lingner Riccardo Dalla-Favera. 1999. Direct activition of TERT transcription by c-MYC. Nat Genet 21:220-224.
20. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8(10):1039-1048.
21. Mateyak MK, Obaya AJ, Sedivy JM. 1999. c-Myc regulates cyclin D-Cdk4 and - Cdk6 activity but affects cell-cycle progression at multiple independent points. Mol Cell Biol 19(7):4672-4683.
22. Miliani de Marval PL, Macias E, Rounbehler R, Sicinski P, Kiyokawa H, Johnson DG, Conti CJ, Rodriguez-Puebla ML. 2004. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol 24(17):7538-7547.
23. Neufeld TP, Edgar BA. 1998. Connections between growth and the cell-cycle. Curr Opin Cell Biol 10(6):784-790.
24. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK, Sedivy JM. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278(14):12563-12573.
25. Ortega S. Malumbres M. Barbacid M. 2002. Cell-cycle and cancer: The G1 restriction point and the G1/S transition. Curr Genomics 3(4):245-263.
26. Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS, Brielmeier M, Ellwart J, Kohlhuber F, Bornkamm GW, Polack A, Eick D. 2000. Cell-cycle activation by c-myc in a Burkitt lymphoma model cell line. Int J Cancer 87(6):787-793.
27. Perez-Roger I, Solomon DL, Sewing A, Land H. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14(20):2373-2381.
28. Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. 1999. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J 18(19):5310-5320.
29. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M. 1994. Repression of cyclin D1: A novel function of MYC. Mol Cell Biol 14(6):4032-4043.
30. Pusch O, Bernaschek G, Eilers M, Hengstschlager M. 1997. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene 15(6):649-656.
31. Rajabi HN, Baluchamy S, Kolli S, Nag A, Srinivas R, Raychaudhuri P, Thimmapaya B. 2005. Effects of depletion of CREB-binding protein on c-Myc regulation and cell-cycle G1-S transition. J Biol Chem 280(1):361-374.
32. Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ. 1995. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Ann Thorac Surg 60(6):1583-1591.
33. Rudolph B, Saffrich R, Zwicker J, Henglein B, Muller R, Ansorge W, Eilers M. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J 15(12):3065-3076.
34. Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J. 2000. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell Biol 20(10):3497-3509.
35. Schuhmacher M, Staege MS, Pajic A, Polack A, Weidle UH, Bornkamm GW, Eick D, Kohlhuber F. 1999. Control of cell growth by c-Myc in the absence of cell division. Curr Biol 9(21):1255-1258.
36. Schuhmacher M, Kohlhuber F, Holzel M, Kaiser C, Burtscher H, Jarsch M, Bornkamm GW, Laux G, Polack A, Weidle UH, Eick D. 2001. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 29(2):397-406.
37. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501-1512.
38. Shichiri M, Hanson KD, Sedivy JM. 1993. Effects of c-myc expression on proliferation, quiescence, and the G0 to G1 transition in nontransformed cells. Cell Growth Differ 4(2):93-104.
39. Shiffman D, Brooks EE, Brooks AR, Chan CS, Milner PG. 1996. Characterization of the human cyclin-dependent kinase 2 gene. Promoter analysis and gene structure. J Biol Chem 271(21):12199-12204.
40. Solomon DL, Philipp A, Land H, Eilers M. 1995. Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene 11(9):1893-1897.
41. Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J, Eilers M. 1995. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. Embo J 14(19):4814-4826.
42. Stella Pelengaris MKaGE. 2002. c-myc: More than just a matter of life and death. Nat Rev Cancer 2:764-776.
43. Ushmorov A, Debatin KM, Beltinger C. 2005. Growth Inhibition of Murine Neuroblastoma cells by c-myc with cell-cycle arrest in G(2)/M. Cancer Biol Ther 4(2):181-186.
44. Wang YH, Liu S, Zhang G, Zhou CQ, Zhu HX, Zhou XB, Quan LP, Bai JF, Xu NZ. 2005. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 7(2):R220-228.
45. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE. 2001. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20(14):1688-1702.
46. Zajac-Kaye M. 2001. Myc Oncogene: A key component in cell-cycle regulation and its implication for lung cancer. Lung Cancer 34(Suppl 2):S43-46.